<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1007601.ref054">
 <label>54</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Roberts</surname>
   <given-names>JL</given-names>
  </name>, 
  <name>
   <surname>Tavallai</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Nourbakhsh</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Fidanza</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Cruz-Luna</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Smith</surname>
   <given-names>E</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>GRP78/Dna K Is a Target for Nexavar/Stivarga/Votrient in the Treatment of Human Malignancies, Viral Infections and Bacterial Diseases</article-title>. 
  <source>J Cell Physiol</source>. 
  <year>2015</year>;
  <volume>230</volume>(
  <issue>10</issue>):
  <fpage>2552</fpage>â€“
  <lpage>78</lpage>. Epub 2015/04/11. 
  <pub-id pub-id-type="doi">10.1002/jcp.25014</pub-id> .
  <?supplied-pmid 25858032?>
  <pub-id pub-id-type="pmid">25858032</pub-id>
 </mixed-citation>
</ref>
